| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |